KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) FCF Margin (2016 - 2025)

Resmed (RMD) has disclosed FCF Margin for 17 consecutive years, with 21.87% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin fell 59.0% year-over-year to 21.87%, compared with a TTM value of 33.19% through Dec 2025, up 494.0%, and an annual FY2025 reading of 32.29%, up 450.0% over the prior year.
  • FCF Margin was 21.87% for Q4 2025 at Resmed, down from 31.02% in the prior quarter.
  • Across five years, FCF Margin topped out at 43.19% in Q1 2025 and bottomed at 10.29% in Q3 2021.
  • Average FCF Margin over 5 years is 20.66%, with a median of 22.28% recorded in 2024.
  • The sharpest move saw FCF Margin crashed -2764bps in 2021, then surged 2160bps in 2023.
  • Year by year, FCF Margin stood at 21.17% in 2021, then plummeted by -54bps to 9.8% in 2022, then skyrocketed by 119bps to 21.46% in 2023, then grew by 5bps to 22.46% in 2024, then decreased by -3bps to 21.87% in 2025.
  • Business Quant data shows FCF Margin for RMD at 21.87% in Q4 2025, 31.02% in Q3 2025, and 37.7% in Q2 2025.